The Majority of Surveyed U.S. Neurologists Selected Tysabri as the Most Effective Therapy for the Treatment of Relapsing-Remitting Multiple Sclerosis, When Compared to Other Currently Available Agents
April 21, 2011
However, No Surveyed MCO Pharmacy Directors Chose Tysabri as the Most Efficacious Agent for the Indication, According to Findings from Decision Resources
Decision Resources’ analysis of the multiple sclerosis drug market reveals that surveyed neurologists’ overwhelming response is consistent with the perception among interviewed experts that Tysabri is the most effective therapy for relapsing-remitting multiple sclerosis—a view supported by clinical studies and clinical experience that suggest the drug’s efficacy is superior to other current agents. Surveyed neurologists indicate a high level of satisfaction with Tysabri’s efficacy, more specifically its impact on relapses (which is sizable compared with other current therapies), disability progression and lesions.
CLICK HERE to continue
****************************************************************
Remain CURRENT with Multiple Sclerosis information
when registered at the MS Views and News website
..
"Providing You with 'MS Views and News', is what we do"
***************************************************************************************
.Disclaimer: 'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
.
****************************************************************
0 comments:
Post a Comment